Al Goldman
Al Goldman
al care defensive economy gore great growth matter money radical stocks supposedly thinks track washington white
Pfizer's a great company, great track record. The economy is slowing, so I think money is going to see defensive growth stocks like the pharmaceuticals and I really don't care what Al Gore thinks about supposedly big drug companies. We're going to have gridlock in Washington and there's not going to be any radical legislation no matter who is in the White House.
although chance cut dramatic fed january move surprise today
It was a surprise although we thought it was a 50-50 chance the Fed would cut before the January meeting. The Fed made a dramatic move today and it was needed. The Fed is now our friend.
although believe bottom bull far health improve line market ran remove
The bottom line is the market ran too far too fast, and we have to remove the excesses. Believe it or not, although corrections are no fun, they do improve the health of the long-term bull market.
almost builds caution chain coming high level market mood reaction selling
The mood in the market is one of a high level of caution. When you get some selling coming in, it's almost like a chain reaction -- it builds on itself.
adjust along came economy election gave growth market patient recovering signs slowing trying until
The market has been trying to adjust to signs of a slowing economy and a deceleration in the growth of earnings, not a deterioration a deceleration, ... We were doing better until the election snafu came along and gave a just recovering patient a relapse.
both buying notorious opportunity rather sector sooner
The sector is notorious for over-reacting - both up and down - and now we are getting a little realistic. But I think the buying opportunity is going to be sooner rather than later.
areas market
These are the personalities of a market getting in the areas of a bottom.
ancient earnings fourth looking market quarter
Earnings are ancient history. The first quarter is under our belt. The market is now looking to the fourth quarter and ahead.
companies hit might prices rebound sharp since stock
Drug companies are being hit by the Merck trial. But since their valuations are still cheap, we might see a sharp rebound in their stock prices soon.
drop earlier excuse finally good home lock managers provided report sales sell stocks
Earlier this year, home-builder stocks were going up like Superman. Today's drop in the home sales report provided a good excuse for managers to finally sell those stocks and lock in some profits.
economic good news normal recovery
Fluctuation is normal after a run-up. The economic news is not good and it's not going to be good for a while, but we are in recovery mode.
action based irrational market somewhere sound stage starts totally worry
Right now this is a market based on sound fundamentals. I do not see any irrational exuberance. I see intelligent buying. Somewhere out there we will get into a blow-off stage but when that will come is totally unpredictable. Therefore, I'll worry about it when market action starts to change.
despite economy improvement signs
Our economy is doing well despite what is going on in Asia, and with any signs of improvement from there, it could be up, up and away for us.
fed meeting raise rates
We do not think the Fed will raise rates at their meeting at the end of this month.